Aquestive Therapeutics Inc (AQST) — Capital Reinvestment Ratio
Aquestive Therapeutics Inc (AQST) has a Capital Reinvestment Ratio of 0.00x as of March 2023, meaning it reinvests 0% of its operating cash flow ($8.82 Million) in capital expenditures ($2.00K). Check AQST tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Aquestive Therapeutics Inc Capital Reinvestment Ratio (2017–2017)
This chart tracks Aquestive Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Aquestive Therapeutics Inc (AQST) cash flow conversion.
Annual Capital Reinvestment Ratio for Aquestive Therapeutics Inc (2017–2017)
Year-by-year Capital Reinvestment Ratio for Aquestive Therapeutics Inc from 2017 to 2017. See Aquestive Therapeutics Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 0.36x | $5.82 Million | $2.07 Million | — |